FG
BEAT

Formula Growth’s BioTelemetry, Inc. BEAT Stock Holding History

Formula Growth’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-24,019
Closed -$446K – 171
2016
Q3 		$446K Sell
24,019
-27,300
-53% -$515K 0.1% 146
2016
Q2 		$836K Sell
51,319
-5,000
-9% -$73.6K 0.2% 133
2016
Q1 		$658K Buy
56,319
+25,000
+80% +$279K 0.16% 141
2015
Q4 		$366K Buy
+31,319
New +$396K 0.09% 153

Other funds holding BEAT

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return

Formula Growth's BEAT Position: Q4 2016 in Review

Formula Growth sold out of BioTelemetry, Inc. (BEAT) in Q4 2016, closing a stake of 24,019 shares — an estimated $446K sold.

Formula Growth first reported a position in BEAT in Q4 2015 and held it in 4 quarters. The position peaked at $836K in Q2 2016. 160 funds tracked by Wall St. Rank hold BEAT as of Q4 2016.

  • Formula Growth reported no remaining BioTelemetry, Inc. position as of Q4 2016 after selling out during the quarter.
  • Formula Growth sold 24,019 BioTelemetry, Inc. shares in Q4 2016, an estimated $446K.
  • Formula Growth first reported a position in BioTelemetry, Inc. in Q4 2015 and held it in 4 quarters.
  • Formula Growth's BioTelemetry, Inc. position peaked at $836K in Q2 2016.
  • 160 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q4 2016.

Based on Formula Growth's 13F filing for Q4 2016, filed 13 Feb 2017.